Mitigation measures against Coronavirus Disease 2019 (COVID-19) in overnight faith-based camps: summer 2021.

OBJECTIVE: In this study, we describe community-based nonpharmaceutical interventions (NPIs) incorporated into COVID-19 mitigation protocols, and SARS-CoV-2 incidence at five faith-based summer camps in the US. STUDY DESIGN: Retrospective cohort study. METHODS: Six southeastern states within the United States (13 sites) were assessed from May 30 to August 14, 2021 (13 sites; N = 13,132; May-August 2021). Camp mitigation policies and NPIs (including masking, vaccinations, meal arrangements, physical distancing, pre-arrival testing, symptom screening, quarantine/isolation, and ventilation upgrades), and SARS-CoV-2 infections were tracked at each site. RESULTS: The symptomatic primary case attack rate was 24.7 (range: 0.0-120.0) cases per 100,000 people per week. Fewer infections were observed in camps with greater mitigation protocols. CONCLUSION: These findings suggest that nonpharmaceutical mitigation can promote stable access to youth programs for historically vaccine-hesitant subgroups. Policy recommendations for nonpharmaceutical interventions to prevent respiratory viral transmission in overnight youth faith-based camp settings may include outdoor activities, accessible symptomatic tests, prearrival testing, indoor mask use, small cohorts, physical distancing, and protocols to minimize staff exposures during time off.

Treatment Outcomes of Stereotactic Ablative Body Radiotherapy on Extra-cranial Oligometastatic and Oligoprogressive Breast Cancer: Mature Results from a Single Institution Experience.

AIMS: Evidence shows stereotactic ablative body radiotherapy (SABR) is used as a non-invasive ablative therapy in the treatment of multisite oligometastatic (OM) and oligoprogressive (OP) diseases originating from metastatic breast cancer. This study aims to report the treatment outcomes and to investigate what factors that are prognostic in terms of local control, progression-free survival (PFS) and overall survival (OS) in patients receiving SABR for extracranial OM and OP diseases originating from metastatic breast cancer. MATERIALS AND METHODS: A retrospective review on treatment records of patients with OM and OP from metastatic breast cancer who underwent SABR at a single was carried out. SABR was performed with daily image-guided radiotherapy (IGRT) using a dedicated robotic SABR machine. Local control, PFS and OS were calculated using Kaplan-Meier statistics and the post-treatment toxicity data was scored following the CTCAE v4.0 protocol. Univariate and multivariate Cox regression tests were used in the subgroup analysis of prognostic factors on PFS and OS including patients' age, types of follow-up imaging (staging CT only vs whole-body MR/PET), metastases status (OM vs OP), primary breast cancer tumour grade, hormone receptors (ER/PR/HER2) status, change of systemic treatments at SABR, number of metastases, SABR treatment sites and doses. RESULTS: 56 metastatic breast cancer patients (38 patients with OM and 18 patients with OP) were involved in this retrospective review. The median follow-up was 35.6 months (range 4.0-132.9 months). The estimated local control at 1 , 2 and 5 years were 90.9%, 88.7% and 88.7%, respectively. The estimated median PFS was 19.2 months (95%CI 10.3-28.1 months); the PFS at 1, 2 and 5 years were 63.3%, 44.4% and 33.2%. The estimated OS at 1, 2 and 5 years were 98.0%, 91.9% and 74.3%, respectively with the estimated median OS of 105.1 months (95%CI 51.5-158.7 months). The vast majority of patients tolerated the treatment well with the commonest acute side effects as grade 1 fatigue. There were no statistically significant factors found in OS regression analysis. The types of follow-up imaging, metastases status, oestrogen receptor status, and number of metastases for SABR were statistically significant factors (p < 0.05) in the multivariate Cox regression analysis on PFS. CONCLUSION: There are limited studies published on the efficacy and post-treatment toxicities of metastatic breast cancer OM and OP SABR with adequate length of follow-up. This study confirmed that SABR was a safe, non-invasive treatment option for patients with extracranial OM and OP diseases originated from primary breast cancer in terms of the acceptable post-treatment toxicities.

Efectos del entrenamiento muscular inspiratorio/espiratorio sobre función respiratoria de pacientes tetrapléjicos / Effects of inspiratory/expiratory muscular training on respiratory function in quadriplegic patients

Introduction: Functional impairment in patients with high spinal cord injuries is associated to ventilatory dysfunction due to paretic respiratory muscles, which causes alterations in the ventilatory and in the cough mechanisms. Respiratory muscle training has been studied as a therapeutic alternative for this group of patients with no conclusive results, whereas a mixed protocol, which stimulates both inspiratory and expiratory muscles, had not been previously investigated. Objective: To evaluate the effects of systematic respiratory muscle training during four months, on pulmonary function, respiratory muscles strength and effort tolerance, cough efficacy and dyspnea perception, in a group of quadriplegic patients with at least one year of evolution post injury. Method: A quasi-experimental design was used. Six adults with cervical spinal cord injuries were enlisted and incorporated in a mixed respiratory muscles training for four months. Pulmonary function, respiratory muscles strength and resistance, cough efficacy and dyspnea perception were assessed pre and post training. Results: The application of the mixed training protocol significantly improved inspiratory muscle strength (p = 0,028),respiratory muscles effort tolerance (p = 0,028) and cough efficacy (p = 0,034).The other measures did not reach statistical significance. Conclusion: Mixed(inspiratory/expiratory) muscular training, shows partially favorable results in the improvement of pulmonary function. Studies using greater numbers of patients are necessary to achieve more categorical results.

Introducción: El compromiso funcional en pacientes con lesiones medulares altas se asocia a disfunción ventilatoria por paresia de musculatura respiratoria y provoca alteraciones ventilatorias y en el mecanismo de la tos. El entrenamiento de la musculatura respiratoria ha sido analizado como alternativa terapéutica para neumo este grupo de pacientes sin resultados concluyentes, mientras que un protocolo mixto, que estimule músculos inspiratorios y espiratorios no ha sido estudiado con anterioridad. Objetivo: Evaluar la respuesta del sistema respiratorio al entrenamiento sistemático de la musculatura respiratoria durante cuatro meses, sobre la función pulmonar, fuerza y tolerancia al esfuerzo de la musculatura respiratoria, eficacia de la tos y percepción de disnea de un grupo de pacientes tetrapléjicos. Materiales y Métodos: Se aplicó un diseño cuasi-experimental. Seis pacientes con lesiones medulares cervicales de al menos un año de evolución fueron reclutados e incluidos en un programa de entrenamiento mixto de la musculatura respiratoria durante 4 meses. Se evaluó la función pulmonar, fuerza y resistencia de la musculatura respiratoria, eficacia de la tos y percepción de disnea antes y después del período de entrenamiento. Resultados: El protocolo de entrenamiento mixto aplicado incrementó significativamente la fuerza muscular inspiratoria (p= 0,028), la tolerancia al esfuerzo de los músculos respiratorios (p = 0,028) y la eficacia de la tos (p = 0,034). El incremento en todas las otras variables medidas no alcanzó significancia estadística. Conclusión: El entrenamiento muscular mixto(inspiratorio/espiratorio) muestra resultados parcialmente favorables en la mejoría de indicadores de función pulmonar. Estudios de mayor número de pacientes son necesarios para acceder a resultados más categóricos.